artenimol has been researched along with Carcinoma, Epidermoid in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Jiang, Q; Li, J; Qiu, J; Xue, D; Ye, F; Zhang, S; Zhou, Q | 1 |
Bao, B; Cheng, B; Hu, R; Ji, Y; Li, X; Liao, G; Luo, H; Ouyang, H; Shi, S; Wang, L; Wang, X; Wang, Y; Wang, Z; Xia, J; Xu, B | 1 |
Lin, JN; Liu, ZZ; Zhao, YX; Zhou, GP | 1 |
Li, Z; Liu, J; Teng, M; Wang, Y | 1 |
Bai, J; Li, J; Li, S; Li, X; Shi, X; Wang, L; Wang, Z; Zhou, M | 1 |
Efferth, T; Erich, SA; Fleckenstein, L; Grinwis, GC; London, CA; Mol, JA; Rutteman, GR; Spee, B | 1 |
Hui, HY; Liu, Y; Wu, M; Wu, N; Xiao, SX; Zhang, MF | 1 |
Jia, L; Li, H; Li, X; Lu, X; Ma, X; Pi, L; Shen, Y; Song, Q; Zhou, C | 1 |
8 other study(ies) available for artenimol and Carcinoma, Epidermoid
Article | Year |
---|---|
Dihydroartemisinin Induces ER Stress-Mediated Apoptosis in Human Tongue Squamous Carcinoma by Regulating ROS Production.
Topics: Apoptosis; Artemisinins; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Reactive Oxygen Species; Tongue; Tongue Neoplasms | 2022 |
Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Head and Neck Neoplasms; Humans; Mice; Mitochondria; Mouth Neoplasms; Oxidative Stress; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2023 |
[Effect of dihydroartemisinin on multidrug resistance of human oral squamous cell carcinoma cell line KBV200 by regulating ROS-MAPK pathway].
Topics: Artemisinins; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Humans; Mouth Neoplasms; Reactive Oxygen Species | 2019 |
Dihydroartemisinin inhibits activation of the AIM2 inflammasome pathway and NF-κB/HIF-1α/VEGF pathway by inducing autophagy in A431 human cutaneous squamous cell carcinoma cells.
Topics: Apoptosis; Artemisinins; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammasomes; NF-kappa B; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2021 |
Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress.
Topics: Animals; Artemisinins; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; DNA Breaks, Double-Stranded; Humans; Models, Biological; Oxidative Stress; STAT3 Transcription Factor; Tongue Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Safety and efficacy field study of artesunate for dogs with non-resectable tumours.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Cell Proliferation; Dog Diseases; Dogs; Lymphoma; Mouth Neoplasms; Treatment Outcome; Tumor Cells, Cultured | 2013 |
Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt/β-catenin pathway.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; beta Catenin; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Inhibitor of Apoptosis Proteins; Signal Transduction; Skin Neoplasms; Survivin; Wnt Proteins | 2016 |
Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.
Topics: Animals; Apoptosis; Artemisinins; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Flow Cytometry; Head and Neck Neoplasms; Humans; Janus Kinase 2; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Tumor Cells, Cultured; Wound Healing; Xenograft Model Antitumor Assays | 2016 |